Why Scholar Rock Stock Is Skyrocketing Today
Shares of Scholar Rock Holding Corporation (NASDAQ: SRRK) were skyrocketing 74.2% higher as of 10:18 a.m. EDT on Tuesday. The huge jump came after the company announced positive interim results from a phase 2 study evaluating experimental drug SRK-015 in treating patients with type 2 and type 3 spinal muscular atrophy (SMA).
As you might expect from today's big gain for the biotech stock, Scholar Rock's clinical results knocked the socks off investors. The company reported significant motor function improvements for all three treatment cohorts in the phase 2 study of SRK-015 at the six-month mark following treatment.
Image source: Getty Images.
Source Fool.com